Table 1.
Unmatched cohorts | Matched cohorts | |||||
---|---|---|---|---|---|---|
COVID‐19 Cohort | Non‐COVID‐19 cohort | Standardized difference | COVID‐19 Cohort | Non‐COVID‐19 cohort | Standardized difference a | |
n = 5620 | n = 2,656,654 | n = 5617 | n = 11,225 | |||
Demographics | ||||||
Age (median, IQR) | 81 (73–88) | 74 (70–81) | 0.52 | 81 (73–88) | 81 (72–88) | 0b |
Female, N (%) | 2134 (38.0%) | 1,417,611 (53.4%) | 0.31 | 2134 (38.0%) | 4268 (38.0%) | 0b |
Highest income quintile | 1586 (28.2%) | 543,536 (20.5%) | 0.18 | 1585 (28.2%) | 2827 (25.2%) | 7% |
Lowest income quintile | 914 (16.3%) | 536,212 (20.2%) | 0.1 | 914 (16.3%) | 1951 (17.4%) | 3% |
Residing in long term care, N (%) | 2851 (50.7%) | 60,142 (2.3%) | 1.31 | 2848 (50.7%) | 5687 (50.7%) | 0b |
Comorbidities in the previous 2 years, N (%) | ||||||
COPD | 459 (8.2%) | 144,742 (5.4%) | 0.11 | 459 (8.2%) | 923 (8.2%) | 0 |
Diabetes | 1563 (27.8%) | 523,953 (19.7%) | 0.19 | 1562 (27.8%) | 2420 (21.6%) | 15% |
Congestive heart failure | 655 (11.7%) | 129,219 (4.9%) | 0.25 | 654 (11.6%) | 982 (8.7%) | 9% |
Hypertension | 2275 (40.5%) | 759,355 (28.6%) | 0.25 | 2274 (40.5%) | 3170 (28.2%) | 26% |
Heart disease | 311 (5.5%) | 96,015 (3.6%) | 0.09 | 310 (5.5%) | 501 (4.5%) | 5% |
Stroke/TIA | 584 (10.4%) | 72,057 (2.7%) | 0.31 | 584 (10.4%) | 880 (7.8%) | 9% |
Obesity | 138 (2.5%) | 53,402 (2.0%) | 0.03 | 138 (2.5%) | 149 (1.3%) | 8% |
Chronic kidney disease | 366 (6.5%) | 108,554 (4.1%) | 0.11 | 365 (6.5%) | 537 (4.8%) | 7% |
Cancer | 409 (7.3%) | 187,737 (7.1%) | 0.01 | 409 (7.3%) | 709 (6.3%) | 4% |
Prior urologist visit | 615 (10.9%) | 260,107 (9.8%) | 0.04 | 615 (10.9%) | 1049 (9.3%) | 5% |
Abbreviations: IQR, interquartile range; COPD, chronic obstructive pulmonary disease; COVID‐19, coronavirus disease 2109; TIA, transient ischemic attack.
Standardized differences are better at demonstrating potentially clinically relevant differences (>10%) between large groups.
The variables age, sex, and residing in long‐term care were used to create the matched cohorts.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.